Clinical trials in Corpus Christi, TX

18 recruiting studies have a site in or near Corpus Christi, TX, Texas.

Top conditions here

All conditions

Showing 18 of 18 studies

RecruitingPhase 2NCT06317662

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Sponsor: National Cancer Institute (NCI)

Austin, TX · Corpus Christi, TX · Dallas, TX · +112 more sites

RecruitingPhase 3NCT06307665

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

Sponsor: AstraZeneca

Austin, TX · Baytown, TX · Beaumont, TX · +117 more sites

RecruitingPhase 3NCT07351045

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Sponsor: Hoffmann-La Roche

Bellaire, TX · Brownsville, TX · Corpus Christi, TX · +41 more sites

RecruitingPhase 3NCT07621809

Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden

Sponsor: Novartis Pharmaceuticals

Bellaire, TX · Corpus Christi, TX · Euless, TX · +17 more sites

RecruitingPhase 2NCT07737743

A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease

Sponsor: Novartis Pharmaceuticals

Allen, TX · Bellaire, TX · Corpus Christi, TX · +6 more sites

RecruitingPhase 2NCT06972446

A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis

Sponsor: AbbVie

Austin, TX · Carrollton, TX · Corpus Christi, TX · +46 more sites

RecruitingPhase 3NCT07222332

A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

Sponsor: Eli Lilly and Company

Corpus Christi, TX · +4 more sites

RecruitingPhase 3NCT06672549

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Sponsor: Eli Lilly and Company

Austin, TX · Corpus Christi, TX · Houston, TX · +47 more sites

RecruitingPhase 3NCT07332481

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

Sponsor: EMD Serono Research & Development Institute, Inc.

Allen, TX · Corpus Christi, TX · +9 more sites

RecruitingPhase 3NCT07668414

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Sponsor: Novo Nordisk A/S

Amarillo, TX · Austin, TX · Brownsville, TX · +42 more sites

RecruitingPhase 3NCT06439277

A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)

Sponsor: Eli Lilly and Company

Corpus Christi, TX · DeSoto, TX · Fort Worth, TX · +11 more sites

RecruitingPhase 3NCT04293562

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Sponsor: Children's Oncology Group

Austin, TX · Corpus Christi, TX · Dallas, TX · +183 more sites

RecruitingPhase not listedNCT07175285

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

Sponsor: Bristol-Myers Squibb

Corpus Christi, TX · Denton, TX · El Paso, TX · +23 more sites

RecruitingPhase 3NCT07797335

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

Sponsor: Novo Nordisk A/S

Amarillo, TX · Austin, TX · Conroe, TX · +106 more sites

RecruitingPhase 1 / Phase 2NCT04726241

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Sponsor: PedAL BCU, LLC

Austin, TX · Corpus Christi, TX · Dallas, TX · +161 more sites

RecruitingPhase 3NCT07567001

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Sponsor: Novo Nordisk A/S

Amarillo, TX · Austin, TX · Conroe, TX · +203 more sites

RecruitingPhase 2NCT06810726

Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.

Sponsor: Estar Medical dba Medical Technologies, LTD

Corpus Christi, TX

Not yet recruitingPhase 3NCT07668336

A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes

Sponsor: Eli Lilly and Company

Beaumont, TX · Corpus Christi, TX · Edinburg, TX · +14 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.